Fingerprint
Dive into the research topics of 'A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically